Skip to content

A random, multi-center controlled trial for Qi-Jing Hui-Xin Decoction in the treatment of microvascular angina

A random, multi-center controlled trial for Qi-Jing Hui-Xin Decoction in the treatment of microvascular angina

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002719
Enrollment
Unknown
Registered
2019-10-28
Start date
2019-11-04
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

microvascular angina

Interventions

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years old; 2. It conforms to the diagnostic criteria of smicrovascular angina (CSS angina severity grade I-III); 3. Those who accord with traditional Chinese medical syndrome meet the above TCM syndrome differentiation; 4. Sign informed consent and be Willing to accept Chinese medicine treatment.

Exclusion criteria

Exclusion criteria: 1. severe heart disease (unstable angina, severe arrhythmia, etc.), Chest pain caused by diseases other than coronary artery disease, such as psychosis, severe neurosis, hyperthyroidism, biliary heart syndrome, gastroesophageal reflux, aortic dissection, etc.; 2. Complicated with uncontrolled grade III hypertension (systolic blood pressure (> 180 mmHg) and/or diastolic blood pressure (> 110 mmHg), severe cardiopulmonary dysfunctionsevere arrhythmia; 3. The patients with liver, kidney, hematopoietic system and other serious diseases, and other serious primary disease; 4. Those who participated in other drug clinical trials within one month; 5. Recently (over 4 weeks) who have undergone major surgery; 6. Pregnancy, lactating women or pregnant planners; 7. Anaphylaxis or allergic to the test drug ingredients1.

Design outcomes

Primary

MeasureTime frame
The effect of angina pectoris;Improvement of TCM syndromes;

Secondary

MeasureTime frame
echocardiographic diagnosis;serum lipid level;Seattle Angina Scale score;EKG efficacy;

Countries

China

Contacts

Public ContactRuan Xiaofen

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

rxfzdl@163.com+86 18018512332

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026